Inhibiting PAC1 receptor internalization and endosomal ERK pathway activation may ameliorate hyperalgesia in a chronic migraine rat model
Cephalalgia · 2023
DOI: 10.1177/03331024231163131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cephalalgia, 2023. Verfasst von Lily Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I, Migraine Disorders. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Natural Science Foundation of Hubei Province, the National Natural and Science Foundation of China.
Abstract (Originalsprache)
Background
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a multipotent neuropeptide widely distributed in the trigeminovascular system (TVS) and higher brain regions. At present, the underlying mechanism of PACAP/PACAP type1 (PAC1) receptor in migraine generation remains unclear.
Methods
The rat model of chronic migraine (CM) was established by repeated intraperitoneal injection of nitroglycerin (NTG). Von Frey filaments and hot plate tests were used to measure the mechanical and thermal thresholds. The expression levels of c-Fos, calcitonin gene-related peptide (CGRP), PACAP, PAC1, protein kinase A (PKA) and phosphorylated extracellular signal-regulated kinase (ERK) were assessed by western blotting or immunofluorescence staining. The internalization of PAC1 receptor was visualized by fluorescence microscope and laser scanning confocal microscope.
Results
The results showed that c-Fos and CGRP expression significantly increased after repeated administrations of NTG or PACAP. Pitstop2 notably improved hyperalgesia in CM rats, while PACAP6–38 offered no benefit. In addition, PACAP-induced PAC1 receptor internalization, PKA and ERK pathways activation were blocked by Pitstop2 instead of PACAP6–38.
Conclusions
Our results demonstrate that inhibition of PAC1 receptor internalization could effectively improve allodynia in CM rats by restraining ERK signaling pathway activation in a chronic migraine rat model. Modulation of receptor internalization may be a novel perspective to explore specific mechanisms of PACAP signaling activation in the trigeminal vascular system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China.
- Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
ORCID-Profile: Zheman Xiao
Förderung
- the Natural Science Foundation of Hubei Province
- the National Natural and Science Foundation of China
Zitieren
APA
Zhang, L., Zhou, Y., Wang, Y., Yang, L., Wang, Y., Shan, Z., Liang, J., & Xiao, Z. (2023). Inhibiting PAC1 receptor internalization and endosomal ERK pathway activation may ameliorate hyperalgesia in a chronic migraine rat model. Cephalalgia. https://doi.org/10.1177/03331024231163131
Vancouver
Zhang L, Zhou Y, Wang Y, Yang L, Wang Y, Shan Z, et al. Inhibiting PAC1 receptor internalization and endosomal ERK pathway activation may ameliorate hyperalgesia in a chronic migraine rat model. Cephalalgia. 2023. doi:10.1177/03331024231163131
BibTeX
@article{Zhang2023,
author = {Zhang, Lily and Zhou, Yanjie and Wang, Yajuan and Yang, Liu and Wang, Yue and Shan, Zhengming and Liang, Jingjing and Xiao, Zheman},
title = {Inhibiting PAC1 receptor internalization and endosomal ERK pathway activation may ameliorate hyperalgesia in a chronic migraine rat model},
journal = {Cephalalgia},
year = {2023},
doi = {10.1177/03331024231163131}
}
EUVIMED